Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Scientists have developed a way to produce a pure source of muscle cells, a technique that might one day prove useful for treating muscle-related diseases.
Scientists have generated early-stage cloned human embryos, but not stem cells.
Harvard researchers are developing the first drug that specifically targets cancer stem cells.
New methods to reprogram adult cells could create novel models of disease.
Researchers are using human embryonic stem cells to determine the toxicity of potential pharmaceuticals.
An easy method for reprogramming adult cells may resolve ethical objections.